• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Clinical Investigators - Disqualification Proceedings

  • Print
  • Share
  • E-mail
  • FDA Home
  • Clinical Investigators - Disqualification Proceedings
-

Compliance and Enforcement

Regulatory Activities

Clinical Investigators - Disqualification Proceedings


Return to Introductory Page
Download Clinical Investigators - Disqualification Proceedings data in Microsoft Excel web format  Click on this link to download all data from the selected searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players .



Advanced Search

   No. of Records Found:  230
Name Center Status Date of status Date NIDPOE Issued Date NOOH Issued Link to NIDPOE Letter Link to NOOH Letter
Borison, Richard L., MD CDER Disqualified 11/10/1998
Khooblall, Khem L., MD CDER Disqualified 06/17/1998
Edwards, Thomas B., MD CDER Restricted 01/26/1998
Rosenthal, C J., MD CDER Disqualified 01/21/1998
Browne, Brian, MD CDER Restrictions Removed 12/23/1997 12/23/1992
Sams, Jr., W Mitchell, MD CDER Disqualified 10/23/1997
Allbritton, Allan R., CVM Disqualified 01/24/1997
Streb, Richard A., MD CDER Disqualified 01/03/1997
Mittelman, Abraham, MD CBER Restrictions Removed 12/09/1995 08/11/1993 12/27/1993
Hofmann, Alan F., MD CDER Restricted 11/21/1995
Garcia, Julio M., MD CDER Restricted 10/19/1995
Boyles, Paul W., MD CDER Disqualified 04/13/1995 07/10/1990 04/26/1991
Garfinkel, Barry D., MD CDER Totally Restricted 05/14/1994
Teplick, Steven K., MD CDER Disqualified 03/08/1994 04/12/1990 03/22/1991
Valdez, Mario P., MD CDER Totally Restricted 02/03/1994
Tewari, Anand, MD CBER Disqualified 11/18/1993 03/23/1995
Kim, Christopher M., MD CBER Not Disqualified 10/20/1993 03/23/1993
Lieberman, Ellin, MD CBER Disqualified 10/12/1993 02/23/1993
Minton, Keith M., DO CDER Disqualified 01/26/1993
Kornblith, Paul, MD CBER Disqualified 11/25/1991 05/29/1991
Paull, Barry R., MD CDER Totally Restricted 11/12/1991
Reagan, Luther M., PhD CVM Disqualified 11/08/1991 07/01/1991
Aroonsakul, Chaovanee, MD CDER Disqualified 10/16/1991 11/24/1989
Slazinski, Leonard, MD CBER Disqualified 08/28/1991 05/14/1991
Roberts, William S., MD CBER Disqualified 07/18/1991 05/14/1991
Poisson, Roger C., MD CDER Disqualified 05/28/1991
Cohn, Cal K., MD CDER Adequate Assurances1 04/17/1991 04/04/1990
Stolman, Lewis P., MD CDER Adequate Assurances1 03/11/1991 11/16/1990
Spiers, Alexander S., MD CDER Reinstated 12/14/1990
Allen, Brady L., MD CDER Disqualified 12/11/1990
Musty, Richard E., MD, PhD CDER Restricted 09/20/1990 06/05/1990
Paulk, Jr., E Alan, MD CDER Disqualified 01/08/1990 05/06/1987 04/18/1988
Reynolds, Jr., James O., MD CDER Restrictions Removed 09/09/1989 04/07/1986
Linker, Charles A., MD CDER Restrictions Removed 05/18/1989 03/31/1988
Levitt, Martin, MD CDER Restrictions Removed 05/02/1989
Fox, Jr., Robert A., MD CDER Disqualified 02/15/1989
Gillespie, Larrian, MD CDER Disqualified 02/02/1989 05/20/1988
Finnerty, Jr., Frank A., MD CDER Restrictions Removed 12/04/1988 12/04/1985
Bushnell, Walter J., MD CDER Disqualified 09/16/1988 03/03/1988
Zackheim, Herschel S., MD CDER Restricted 08/23/1988 03/30/1988
Morton, Robert E., MD CDER Restricted 08/18/1988
Caruso, Walter A., MD CDER Totally Restricted 07/28/1988
Sriratana, Pramern, MD CDER Restricted 06/10/1988
Levinson, Robert A., MD CDER Disqualified 03/31/1988
Fuller, Ronald R., DVM CVM Disqualified 01/29/1988 03/11/1986 08/04/1986
Cullen, Aubrey P., MD CDER Totally Restricted 06/08/1987
Jolly, Jr., Henry W., MD CDER Restrictions Removed 11/17/1986 11/17/1983
Gooding, John M., DO CDER Totally Restricted 11/07/1986 06/19/1984
Kostas, Constantine I., MD CDER Disqualified 10/07/1986
Ali, Nayab, MD CDER Restrictions Removed 06/23/1986 08/06/1980 11/12/1981

Prev  |  Next  |  1  |  2  |  [3]  |  4  |  5  |  First  |  Last  |  All


1.Under regulations in effect until 1987, investigators who met the standard for disqualification (repeated or deliberate failure to comply with applicable requirements) could potentially avoid disqualification and continue to be eligible to receive investigational products if they could provide FDA with adequate assurances of future compliance with requirements applicable to the use of investigational drugs and biologics. The provisions for adequate assurances are no longer in the regulations.



-
-